Glaucoma in Ghana, West Africa: Clinical features and the role of mutations in Myocilin

Ophthalmology Clinics of North America

Volumn 16, Issue 4, 2003, Pages 631-637

  Herndon, Leon W ^a   Challa, Pratap ^a   Allingham, R Rand ^a  

^a DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOCILIN;

ADULT; AFRICA; AGED; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; POPULATION RESEARCH; PRIMARY GLAUCOMA; PRIORITY JOURNAL; REVIEW;

EID: 0346334605     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-1549(03)00070-1     Document Type: Review

References (42)

1. Tielsch JM, Somner A, Katz J, et al. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 1991;266(3):369-74.
2. Leske MC, Connell AMS, Schachat AP, et al. The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol 1994;112(6):821-9.
3. Mason RP, Kosoko O, Wilson MR, et al. National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part I. Prevalence findings. Ophthalmology 1989;96(9):1363-8.
4. Wilensky JT, Gandhi N, Pan T. Racial influences in open-angle glaucoma. Ann Ophthalmol 1978;10(10): 1398-402.
5. Quigley HA, Vitale S. Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci 1997;38(1):83-91.
6. David R, Livingston D, Luntz MH. Ocular hypertension: a comparative follow-up of black and white patients. Br J Ophthalmol 1978;62(10):676-8.
7. Foster A, Johnson GJ. Magnitude and causes of blindness in the developing world. Int Ophthalmol 1990;14(3):135-40.
8. Chatterjee S. Blindness in Ghana and its rehabilitation. Ghana Med J 1970;9:314-5.
9. Faal H, Minassian D, Sowa S, et al. National survey of blindness and low vision in The Gambia: results. Br J Ophthalmol 1989;73(2):82-7.
10. Kayembe L. Common causes of blindness in Zaire. Br J Ophthalmol 1985;69(5):389-91.
11. Stilma JS, Bridger S. Causes and prevalence of blindness in the Northern Province of Sierra Leone. Doc Ophthalmol 1983;56(1-2):115-22.
12. Olurin O. Causes of blindness in Nigeria-a study of 1,000 hospital patients. West Afr Med J Niger Med Dent Pract 1973;22(6):97-107.
13. Neumann EZH, Zauberman H. Glaucoma survey in Liberia. Am J Ophthalmol 1965;59:8-12.
14. Buhrmann RR, Quigley HA, Barron Y, et al. Prevalence of glaucoma in a rural East African population. Invest Ophthalmol Vis Sci 2000;41(1):40-8.
15. Challa P, Herndon LW, Hauser MA, et al. Prevalence of Myocilin mutations in adults with POAG in Ghana, West Africa. J Glaucoma 2002;11:416-20.
16. Sheffield VC, Stone EM, Alward WLM. Genetic linkage of familial open angle glaucoma to chromosome 1q21-q31. Nat Genet 1993;4(1):47-50.
17. Stone EM, Fingert JH, Alward WLM, et al. Identification of a gene that causes primary open angle glaucoma. Science 1997;275(5300):668-70.
18. Kitsos G, Eiberg H, Economou-Petersen E, et al. Genetic linkage of autosomal dominant primary open angle glaucoma to chromosome 3q in a Greek pedigree. Eur J Hum Genet 2001;9(6):452-7.
19. Allingham RR, Wiggs JL, De La Paz MA, et al. Gln368STOP Myocilin mutation in families with late-onset primary open-angle glaucoma. Invest Ophthalmol Vis Sci 1998;39(12):2288-95.
20. Angius A, De Gioia E, Loi A, et al. A novel mutation in the GLC1A gene causes juvenile open-angle glaucoma in 4 families from the Italian region of Puglia. Arch Ophthalmol 1998;116(6):793-7.
21. Angius A, Spinelli P, Ghilotti G, et al. Myocilin Gln368stop mutation and advanced age as risk factors for late-onset primary open-angle glaucoma. Arch Ophthalmol 2000;118(5):674-9.
22. Fingert JH, Ying L, Swiderski RE, et al. Characterization and comparison of the human and mouse GLC1A glaucoma genes. Genome Res 1998;8(4):377-84.
23. Fingert J-H, Heon E, Liebmann JM, et al. Analysis of Myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet 1999;8(5): 899-905.
24. Kennan AM, Humphries P, Farrar GJ. A novel Asp380Ala mutation in the GLC1A/Myocilin gene in a family with juvenile onset primary open angle glaucoma. J Med Genet 1998;35(11):957-60.
25. Mabuchi F, Yamagata Z, Kashiwaga K, et al. Analysis of Myocilin gene mutations in Japanese patients with normal tension glaucoma and primary open-angle glaucoma. Clin Genet 2001;59(4):263-8.
26. Mabuchi F, Yamagata Z, Kashiwaga K, et al. A sequence change (Arg158Gln) in the leucine zipper-like motif region of the MYOC/TIGR protein. J Hum Genet 2001;46(2):85-9.
27. Mansergh FC, Kenna PF, Ayuso C, et al. Novel mutations in the TIGR gene in early and late onset open angle glaucoma. Hum Mutat 1998;11(3):244-51.
28. Mardin CY, Veltin I, Ozbey S, et al. A GLC1A gene Gln368Stop mutation in a patient with normal-tension open-angle glaucoma. J Glaucoma 1999;8(2):154-6.
29. Michels-Rautenstrauss KG, Mardin CY, Budde WM, et al. Juvenile open angle glaucoma: fine mapping of the TIGR gene to 1q24.3-q25.2 and mutation analysis. Hum Genet 1998;102(1):103-6.
30. Suzuki R, Hattori Y, Okano K. Promoter mutations of Myocilin gene in Japanese patients with open angle glaucoma including normal tension glaucoma. Br J Ophthalmol 2000;84(9):1078.
31. Taniguchi F, Suzuki Y, Shirato S, et al. The Gly367Arg mutation in the Myocilin gene causes adult-onset primary open-angle glaucoma. Jpn J Ophthalmol 2000;44(4):445-8.
32. Vasconcellos JP, Melo MB, Costa VP, et al. Novel mutation in the MYOC gene in primary open glaucoma patients. J Med Genet 2000;37(4):301-3.
33. Suzuki Y, Shirato S, Taniguchi F, et al. Mutations in the TIGR gene in familial primary open-angle glaucoma in Japan. Am J Hum Genet 1997;61(5):1202-4.
34. Alward WL, Fingert JH, Coote MA, et al. Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A). N Engl J Med 1998;338(15):1022-7.
35. Wiggs JL, Allingham RR, Volrath D, et al. Prevalence of mutations in TIGR/Myocilin in patients with adult and juvenile primary open-angle glaucoma. Am J Hum Genet 1998;63(5):1549-52.
36. Briggs P. Guide to Ghana. Bucks, UK: Bradt Publications; 1998.
37. Choy YS, Dabora SL, Hall F, et al. Superiority of denaturing high performance liquid chromatography over single-stranded conformation and conformation-sensitive gel electrophoresis for mutation detection in TSC2. Ann Hum Genet 1999;63(Pt 5):383-91.
38. Liu W, Smith DI, Rechtzigel KJ, et al. Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. Nucleic Acids Res 1998;26(6):1396-400.
39. Sarkies J. Primary glaucoma amongst Gold Coast Africans. Br J Ophthalmol 1953;37:615-20.
40. Verrey JD, Foster A, Wormald R, et al. Chronic glaucoma in northern Ghana-a retrospective study of 397 patients. Eye 1990;4(Pt 1):115-20.
41. Ball SF. Exfoliation syndrome prevalence in the glaucoma population of South Louisiana. Acta Ophthalmol Suppl 1988;184:93-8.
42. Cashwell Jr LF, Shields MB. Exfoliation syndrome in the southeastern United States. I. Prevalence in open-angle glaucoma and non-glaucoma populations. Acta Ophthalmol Suppl 1988;184:99-102.